Home
SAiGENCI is an independent cancer-focused medical research institute located in South Australia; focusing on cancer research and linking to clinical trials, which will include new cutting-edge technologies in immunotherapies and genomics.
Help make cancer history
100% of your gift will support leading-edge cancer research, which will lead to better outcomes for patients with cancer, and their families.
With your support, we can save lives.
Featured projects
Towards the future: improving survivorship for children with brain cancer
Brain cancer is the most common solid tumour of childhood and most lethal type of cancer in Australian children.
Read more about improving survivorship for children with brain cancerUnlocking the mysteries of prostate cancer
The SAiGENCI team is creating a comprehensive data repository and applying machine learning to uncover revolutionary insights for prostate cancer treatment and prevention.
Read more about Unlocking the mysteries of prostate cancerLeadership appointments
Professor Christopher Sweeney
Professor Christopher Sweeney is SAiGENCI's inaugural Director.
Professor Lisa Butler
Professor Lisa Butler is the Lead SAiGENCI Associate in SAHMRI, and Prostate Cancer Theme Lead in the Hormone Dependent Cancers program. She also leads SAiGENCI’s Graduate Program for HDR and Honours students.
Professor Brendan Jenkins
Professor Brendan Jenkins is Program Lead for the Tumour Inflammation and Immunotherapy program.
Professor Jose Polo
Professor Jose Polo is Program Lead for Cancer Epigenetics in SAiGENCI, building the epigenetics capacity within the Institute. Professor Polo has established the Adelaide Centre for Epigenetics (ACE).
Scientific appointments
Dr Stefano Mangiola
Dr Stefano Mangiola is a Group Leader at SAiGENCI and a VCA Fellow in computational cancer immunology. He leads the Computational Cancer Immunogenomics laboratory at SAiGENCI in the Resistance Prevention program.
Dr Qi Zhang
Dr Qi Zhang is SAiGENCI's first EMBL Australia Group Leader in the Cancer Epigenetics program.
Dr Fuyi Li
Dr Fuyi Li is establishing a research group focusing on developing Artificial Intelligence and Machine Learning approaches for cancer research as a Group Leader in the Computational Systems Oncology program.
Dr Yannan Yang
Dr Yannan Yang is Group Leader, Biomaterials and Immune Engineering Laboratory (BIEL) within the Tumour Inflammation and Immunotherapy program.
Dr Luke Isbel
Dr Luke Isbel holds a joint Group Leader appointment within the South Australian immunoGENomics Cancer Institute (SAiGENCI) and the Adelaide Centre for Epigenetics (ACE), where he will focus on the role of chromatin in development and in disease states like cancer.
Dr Adrienne Sullivan
Dr Adrienne Sullivan holds a Group Leader joint appointment with the Adelaide Centre for Epigenetics (ACE) and SAiGENCI as Head of Development and Epigenetics Laboratory with ACE and SAiGENCI's Cancer Epigenetics program.
Associate Professor Luciano Martelotto
Associate Professor Luciano Martelotto has been appointed to establish a Single Cell and Spatial Technologies Lab for SAiGENCI.
News
29 May
SAiGENCI Annual Public Lecture - Decoding Cancer: How epigenetics could solve the cancer riddle
Held on Tuesday 21 May in the Braggs Lecture Theatre, the SAiGENCI Annual Public Lecture was a great success with 230 attending the live event and 50 viewing online. 23 May
Professor Jose Polo elected as 2024 Fellow of the Australian Academy of Science
SAiGENCI are thrilled to congratulate Professor Jose Polo on his election as a 2024 Fellow of the Australian Academy of Science.
Events
15 Feb
The Adelaide Cancer Seminar Series
The Adelaide Cancer Seminar Series are jointly organised by the South Australian immunoGENomics Cancer Institute (SAiGENCI), Centre for Cancer Biology (CCB) and the South Australian Health and Medical Research Institute (SAHMRI). The aim of the seminar series is to forge links across the research community, foster collaborative links between the researchers within Australia and internationally and to showcase outstanding research being conducted around Australia by top scientists.